Adult T-cell leukemia after immunosuppressive therapy for systemic lupus erythematosus
暂无分享,去创建一个
Tomoki Ito | S. Nomura | K. Ishii | F. Urase | Y. Maeda | S. Fukuhara | M. Shimizu | Y. Ozaki | Y. Shimamoto
[1] C. Tei,et al. Clinical manifestations of human T lymphotropic virus type I-infected patients with systemic lupus erythematosus. , 2007, The Journal of rheumatology.
[2] L. Otvos,et al. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus. , 2005, Clinical immunology.
[3] J. Marchalonis,et al. Endogenous retroviruses in systemic lupus erythematosus: candidate lupus viruses. , 2002, Clinical immunology.
[4] A. Rolfs,et al. Absence of human T‐lymphotrophic virus type I in patients with systemic lupus erythematosus , 1996, Clinical and experimental dermatology.
[5] P. A. Peterson,et al. Interaction of MHC class I molecules with the transporter associated with antigen processing. , 1994, Science.
[6] K. Ohshima,et al. Human T ‐cell leukemia virus type I associated lymphadenitis , 1992 .
[7] B. Verrier,et al. Four regulatory elements in the human c-fos promoter mediate transactivation by HTLV-1 Tax protein. , 1991, Oncogene.
[8] N. Ordóñez,et al. C-type virus expression in systemic lupus erythematosus. , 1976, The New England journal of medicine.